OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
Masashi Bando, Sakae Homma, Hiroshi Date, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 3, pp. 402-418
Closed Access | Times Cited: 7
Masashi Bando, Sakae Homma, Hiroshi Date, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 3, pp. 402-418
Closed Access | Times Cited: 7
Showing 7 citing articles:
Lung Cancer and Interstitial Lung Diseases
Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2837-2837
Open Access | Times Cited: 4
Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2837-2837
Open Access | Times Cited: 4
Potential Utility of Combined Presepsin and LDH Tracking for Predicting Therapeutic Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Interstitial Lung Diseases: A Pilot Study
Yuichiro Takeshita, Yasuo To, Masako To, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3068-3068
Open Access
Yuichiro Takeshita, Yasuo To, Masako To, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3068-3068
Open Access
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery
Simeng Du, Zhiyang Wen, Jinghan Yu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 3
Simeng Du, Zhiyang Wen, Jinghan Yu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 3
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Katyayini Aribindi, Gabrielle Y. Liu, Timothy E. Albertson
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 9, pp. 817-835
Closed Access | Times Cited: 1
Katyayini Aribindi, Gabrielle Y. Liu, Timothy E. Albertson
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 9, pp. 817-835
Closed Access | Times Cited: 1
Idiopatinės plaučių fibrozės ir progresuojančios plaučių fibrozės diagnostikos ir gydymo rekomendacijos 2024 m
Kęstutis Malakauskas, Kristina Biekšienė, Jurgita Zaveckienė, et al.
Pulmonology and allergology (2024) Vol. 8, Iss. 1, pp. 10-25
Open Access
Kęstutis Malakauskas, Kristina Biekšienė, Jurgita Zaveckienė, et al.
Pulmonology and allergology (2024) Vol. 8, Iss. 1, pp. 10-25
Open Access
Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan
Masashi Bando, Hirofumi Chiba, Yasunari Miyazaki, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 5, pp. 785-793
Closed Access
Masashi Bando, Hirofumi Chiba, Yasunari Miyazaki, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 5, pp. 785-793
Closed Access
Treatable traits in idiopathic pulmonary fibrosis: focus on respiratory tract infections—a systematic review and a meta-analysis
Zsombor Matics, Anna Bardóczi, Csongor Galkó, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102966-102966
Open Access
Zsombor Matics, Anna Bardóczi, Csongor Galkó, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102966-102966
Open Access
